ABOUT US

Health comes from heaven, heaven brings hope

Development History

  • Categories:关于我们
  • Time of issue:2020-06-30 00:00:00
  • Views:0
Description:Topfond Pharmaceutical Co., Ltd. is a large-scale comprehensive pharmaceutical enterprise whose main business is the production and management of finished preparations, chemical synthetic APIs and biotechnology APIs.Founded in 1969, Topfond pharmaceutical was listed in Shanghai stock exchange in December 2000. After more than 50 years of hard work, Topfond has grown from small to large, from weak to strong, and now it has developed into a large pharmaceutical group with 5 subsidiaries, 4 production branches, 1 national enterprise technology center and 1 post-doctoral research workstation. It has more than 5000 employees and more than 7 billion yuan of total assets. In August 2008,Topfond joined China General Technology (Group) Holding Co., Ltd. In July 2013, Topfond Pharmaceutical successfully realized the reorganization and mergered with China Meheco and became a wholly-owned subsidiary of China Meheco (stock code: "600056").   Topfond pharmaceutical products mainly involve antibiotics, cardiovascular and cerebrovascular diseases, anti-AIDS, diabetes and other fields.The production and storage of more than 10 dosage forms of nearly 600 varieties and specifications of products.It has an annual production capacity of 10 billion tablets (pellets) of oral solid preparations with antibiotic fermentation capacity of 12000m3. APIs and some pharmaceutical products are exported to more than 30 countries and regions in Western Europe, Southeast Asia, the Middle East, North Africa, etc., which have successfully integrated into the tide of global economic integration.Computer ERP system has been used in production, scientific research, management, circulation and other systems.   ·Over the years, Topfond adheres to the revitalization of the national medicine industry as its own responsibility, relying on science-technology and management of the two-wheel drive to enhance the overall strength of the enterprise constantly and to maintain a steady and rapid development. Topfond’s comprehensive strength and scale has ranked in the forefront of the industry. Topfond won the award of Key Leading Enterprise of National Pharmaceutical Industry, Leading Medicine Production Enterprise of Henan Province , Key High-tech Enterprise of National Torch Plan, Advanced Quality Management Enterprise, National Top 100 Environmental Protection Project, Top 100 Key Enterprises of Henan Province, Key Export Enterprise of Henan Province, First batch of Energy-saving and Emission Reduction Technology Innovation Demonstration Enterprises   of Henan Province, First Batch of Innovative Pilot Enterprises of Henan Province, Intellectual Property Advantage Cultivation Enterprise of Henan Province. "Topfond" trademark is confirmed as "China Well-known Trademark".
Description:Topfond Pharmaceutical Co., Ltd. is a large-scale comprehensive pharmaceutical enterprise whose main business is the production and management of finished preparations, chemical synthetic APIs and biotechnology APIs.Founded in 1969, Topfond pharmaceutical was listed in Shanghai stock exchange in December 2000. After more than 50 years of hard work, Topfond has grown from small to large, from weak to strong, and now it has developed into a large pharmaceutical group with 5 subsidiaries, 4 production branches, 1 national enterprise technology center and 1 post-doctoral research workstation. It has more than 5000 employees and more than 7 billion yuan of total assets. In August 2008,Topfond joined China General Technology (Group) Holding Co., Ltd. In July 2013, Topfond Pharmaceutical successfully realized the reorganization and mergered with China Meheco and became a wholly-owned subsidiary of China Meheco (stock code: "600056").   Topfond pharmaceutical products mainly involve antibiotics, cardiovascular and cerebrovascular diseases, anti-AIDS, diabetes and other fields.The production and storage of more than 10 dosage forms of nearly 600 varieties and specifications of products.It has an annual production capacity of 10 billion tablets (pellets) of oral solid preparations with antibiotic fermentation capacity of 12000m3. APIs and some pharmaceutical products are exported to more than 30 countries and regions in Western Europe, Southeast Asia, the Middle East, North Africa, etc., which have successfully integrated into the tide of global economic integration.Computer ERP system has been used in production, scientific research, management, circulation and other systems.   ·Over the years, Topfond adheres to the revitalization of the national medicine industry as its own responsibility, relying on science-technology and management of the two-wheel drive to enhance the overall strength of the enterprise constantly and to maintain a steady and rapid development. Topfond’s comprehensive strength and scale has ranked in the forefront of the industry. Topfond won the award of Key Leading Enterprise of National Pharmaceutical Industry, Leading Medicine Production Enterprise of Henan Province , Key High-tech Enterprise of National Torch Plan, Advanced Quality Management Enterprise, National Top 100 Environmental Protection Project, Top 100 Key Enterprises of Henan Province, Key Export Enterprise of Henan Province, First batch of Energy-saving and Emission Reduction Technology Innovation Demonstration Enterprises   of Henan Province, First Batch of Innovative Pilot Enterprises of Henan Province, Intellectual Property Advantage Cultivation Enterprise of Henan Province. "Topfond" trademark is confirmed as "China Well-known Trademark".
Information

       Topfond Pharmaceutical Co., Ltd. is a large-scale comprehensive pharmaceutical enterprise whose main business is the production and management of dosage forms, chemical synthetic APIs and biotechnology APIs.Founded in 1969, Topfond pharmaceutical was listed in Shanghai stock exchange in December 2000. After more than 50 years of hard work, Topfond has grown from small to large, from weak to strong, and now it has developed into a large pharmaceutical group with 5 subsidiaries, 4 production branches, 1 national enterprise technology center and 1 post-doctoral research workstation. It has more than 5000 employees and more than 7 billion yuan of total assets. In August 2008,Topfond joined China General Technology (Group) Holding Co., Ltd. In July 2013, Topfond Pharmaceutical successfully realized the reorganization and mergered with China Meheco and became a wholly-owned subsidiary of China Meheco (stock code: "600056").

      Topfond pharmaceutical products mainly involve antibiotics, cardiovascular and cerebrovascular diseases, anti-AIDS, diabetes and other fields.The production and storage of more than 10 dosage forms of nearly 600 varieties and specifications of products.It has an annual production capacity of 10 billion tablets (pellets) of oral solid preparations with antibiotic fermentation capacity of 12000m3. APIs and some pharmaceutical products are exported to more than 30 countries and regions in Western Europe, Southeast Asia, the Middle East, North Africa, etc., which have successfully integrated into the tide of global economic integration.Computer ERP system has been used in production, scientific research, management, circulation and other systems.

·    Over the years, Topfond adheres to the revitalization of the national medicine industry as its own responsibility, relying on science-technology and management of the two-wheel drive to enhance the overall strength of the enterprise constantly and to maintain a steady and rapid development. Topfond’s comprehensive strength and scale has ranked in the forefront of the industry. Topfond won the award of Key Leading Enterprise of National Pharmaceutical Industry, Leading Medicine Production Enterprise of Henan Province , Key High-tech Enterprise of National Torch Plan, Advanced Quality Management Enterprise, National Top 100 Environmental Protection Project, Top 100 Key Enterprises of Henan Province, Key Export Enterprise of Henan Province,  First batch of Energy-saving and Emission Reduction Technology Innovation Demonstration Enterprises of Henan Province, First Batch of Innovative Pilot Enterprises of Henan Province, Intellectual Property Advantage Cultivation Enterprise of Henan Province. "Topfond" trademark is confirmed as "China Well-known Trademark".

Scan the QR code to read on your phone

Tianfang Pharmaceutical

FOREIGN TRADE DEPT.

Tel: 0086-371-65510982/65510983/65510979

Email: topfondexport@vip.163.com 

            export@topfond.com

Address: No. 2 Guangming Road, Zhumadian, Henan Province, China

Copyright ©2020 Topfond Pharmaceutical Co., Ltd.    豫ICP备17030262号

This website already supports IPv6   Powered by www.300.cn